Edtech major BYJU's may lay off up to 3,500 employees during the current fiscal as it looks to consolidate teams and enhance ...

JPMorgan Chase JPM will lay off about 5,000 workers, or about one worker for each of its branches, amid $1.4 billion in cost cuts. JPMorgan Chase JPM will lay off about 5,000 workers, or about one ...

Layoffs continue apace after more than 136,000 employees were cut by major U.S. companies in the first quarter of 2023.

Roku will lay off 10% of its workforce, equating to over 300 employees, in an effort to reign in company costs, according to an SEC filing on Wednesday. The company has made the decision to ...

Google confirmed it will lay off hundreds of staff members who helped recruit and hire employees, as Silicon Valley continues ...

(Reuters) - 2seventy bio said on Tuesday it plans to lay off about 40% of its workforce to lower costs and focus on the biotech firm's cancer cell therapy Abecma. The company will save about $130 ...

Sage Therapeutics said on Thursday that it plans to lay off about 40 percent of its workforce, roughly 275 employees, and shake up its leadership team following a decision by federal regulators to ...

Adds details on job cuts, CEO transition in paragraphs 2-4 Sept 12 (Reuters) - 2seventy bio TSVT.O said on Tuesday it plans to lay off about 40% of its workforce to lower costs and focus on the ...

Roku will lay off 10% of its workforce, equating to over 300 employees, in an effort to reign in company costs, according to an SEC filing on Wednesday. The company has made the decision to reduce ...

Sept 12 (Reuters) - 2seventy bio (TSVT.O) said on Tuesday it plans to lay off about 40% of its workforce to lower costs and focus on the biotech firm's cancer cell therapy Abecma, lifting the ...

Roku will lay off 10% of its workforce, equating to over 300 employees, in an effort to reign in company costs, according to an SEC filing on Wednesday. The company has made the decision to reduce ...

(Reuters) -2seventy bio said on Tuesday it plans to lay off about 40% of its workforce to lower costs and focus on the biotech firm's cancer cell therapy Abecma, lifting the company's shares more ...